期刊文献+

检测视黄醇结合蛋白4在非酒精性脂肪性肝病中的意义 被引量:1

A study on the role of serum Retinol Binding Protein 4 in nonalcoholic fatty liver disease
下载PDF
导出
摘要 目的探讨非酒精性脂肪性肝病(NAFLD)患者血清视黄醇结合蛋白4(RBP4)的临床意义。方法选择NAFLD肝患者62例,正常对照60例,采用ELISA方法测定空腹血清RBP4,同时检测其血糖、血脂、肝功能及胰岛素水平,并计算胰岛素抵抗指数(HOMA-IR)。结果与正常对照组比较,NAFLD患者的空腹血糖(FBG)、总胆固醇(TC)、甘油三酯(TG)、低密度酯蛋白(LDL-C)、血清胰岛素(FINS)、HOMA-IR、ALT、AST和RBP4显著增高(P<0.01),而且NAFLD患者治疗后血清RBP4水平显著降低。相关分析显示,血清RBP4与FBG、TC、TG、FINS、HOMA-IR呈正相关。结论在NAFLD的发病过程中,RBP4可能参与其发病,在其早期诊断和评判肝脏损害程度中有一定的临床意义。 Objective To evaluate the role of serum retinol binding protein 4(RBP4) in patients with nonalcoholic fatty liver disease(NAFLD).Methods 62 patients with nonalcoholic fatty liver disease(NAFLD group) and 60 normal subjects(normal control group) were selected.The level of serum RBP4 was measured by ELISA.Fasting blood glucose(FBG),blood lipid(TC,TG,HDL-C,LDL-C),liver function(AST,ALT),and fasting insulin(FINS) were measured.Homeostasis model assessment of insulin resistance(HOMA-IR) were calculated as well.Results The levels of RBP4,FBG,TC,TG,LDL-C,FINS,ALT,AST and HOMA-IR were higher in NAFLD patients as compared to normal controls(P0.01).The levels of Serum RBP4 were positively correlated with FBG,TC,TG,FINS and HOMA-IR(r=0.329,0.298,0.261,0.219,0.378,P0.01).Conclusion RBP4 was involved in the development of nonalcoholic fatty liver disease.Thus,RBP4 may be used as a sensitive indicator for the pathogenesis and the development of NAFLD,which can assist in early diagnosis of the disease.
作者 郭银燕 李鹏
出处 《临床肝胆病杂志》 CAS 2012年第4期279-280,301,共3页 Journal of Clinical Hepatology
关键词 非酒精性脂肪性肝病 视黄醇结合蛋白质类 血浆 nonalcoholic fatty liver disease retinol binding proteins plasma
  • 相关文献

参考文献6

  • 1中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪肝病诊疗指南.中华肝脏病杂志,2006,14(2):161-161.
  • 2Yang Q,Graham TE,Mody N,et al.Serum retinol bindingprotein 4 contributes to insulin resistance in obesity and type2 diabetes[J].Nature,2005,436(7049):356-362.
  • 3Wu H,Jia W,Bao Y,et al.Serum retinol binding protein 4 andnonalcoholic fatty liver disease in patients with type 2 diabetes[J].Diabetes Res Clin Pract,2008,79(2):185-190.
  • 4Yan KK,Palmer CS,Lloyd AR,et al.Relationship of RetinolBinding Protein-4 with Liver Injury in Morbidly Obese Sub-jects[J].Hepatology,2009,50(4):S789A.
  • 5徐慧,龚环宇,陈丽敏,彭亦,彭丹红.视黄醇结合蛋白4在非酒精性脂肪肝病大鼠组织中的表达[J].现代生物医学进展,2011,11(4):642-645. 被引量:2
  • 6Seo JA,Kim NH,Park SY,et al.Serum retinol binding pro-tein 4 levels are elevated in non-alcoholic fatty liver disease[J].Clin Endocrinol,2008,68(4):555-560.

二级参考文献16

  • 1Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol, 2009;50:204-210.
  • 2Ikegami H, Ogihara T. [Genetic susceptibility to diabetes and hypertensionl. Nippon Rinsho, 2003 Jul;61 (7): 1105-1 2.
  • 3Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotani K, Quadro L, Kahn BB. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes [J]. Nature 2005;436:56-62.
  • 4Seo JA, Kim NH, Park SY, Kim HY, Ryu OH, Lee KW, Lee J, Kim DL, Choi KM, Balk SH, Choi DS, Kim SG. Serum retinol-bindingprotein 4 levels are elevated in non-alcoholic fatty liver disease [J]. Clin Endocrinol (Oxf), 2008;68:555-600.
  • 5Hepatology of Chinese Medical Association and the credits will be alcoholic fatty liver disease Liver Disease Study Group. Non-alcoholic fatty liver disease diagnosis and treatment guidelines [J]. Journal of Chinese Hepatology, 2006, 14 (3): 161-163.
  • 6Sun S, Ning X, Liu J, Lia L, Chen Y, Han S, Zhang Y, Liang J, Wu K, Fan D. Overexpressed CacyBWSIP leads to the suppression of growth in renal cell carcinoma [J]. Biochem Biophys Res Commun, 2007; 356:864-871.
  • 7Tang S, Yang G, Meng Y, Du R, Li X, Fan R, Zhao L, Bi Q, Jin J, Gao L, Zhang L, Li H, Fan M, Wang Y, Wu K, Liu J, Fan D. Overexpressiun of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer[J]. Cancer Biol Ther, 2010;9:88-95.
  • 8Angulo P. Nonalcoholic fatty liver disease. N Engl J Med, 2002,346: 1221-1231.
  • 9Williams R. Global challenges in liver disease. Hepatology, 2006,44: 521-526.
  • 10Fan J G, Zhu J, Li XJ, et al, Prevalence of and risk factors for fat ty liver in a general population of Shanghai ,China. J Hepatol, 2005,43: 508-514.

共引文献23

同被引文献32

  • 1张永红,刘毅,田沂,蒋永芳,梁骏.严重肝病患者尿视黄醇结合蛋白和微量白蛋白检测的临床意义[J].中国医师杂志,2006,8(12):1703-1703. 被引量:2
  • 2王莉.乙型肝炎患者视黄醇结合蛋白和β_2-微球蛋白的检测意义[J].江西医学检验,2007,25(3):287-287. 被引量:2
  • 3梁栋伟,陈斌鸿.血清视黄醇结合蛋白和前白蛋白在肝病诊断中的应用[J].国际医药卫生导报,2007,13(15):127-128. 被引量:10
  • 4Tilg H,Moschen AR.Role of adiponectin and PBEF/visfatin as regulators of inflammation:involvement in obesity-associated diseases[J].Clin Sci(Lond),2008,114(4):275-288.
  • 5Yang Q,Graham TE,Mody N,et al.Serum retinol binding protein 4contributes to insulin resistance in obesity and type 2diabetes[J].Nature,2005,436(7049):356-362.
  • 6Murata M,Saito T,Otani T,et al.An increase in serum retinol-binding protein 4in the type 2diabetic subjects with nephropathy[J].Endocr J,2009,56(2):287-294.
  • 7Huang JF,Dai CY,Yu ML,et al.Serum retinol-binding protein 4is inversely correlated with disease severity of chronic hepatitis C[J].J Hepatol,2009,50(3):471-478.
  • 8Tacke F,Weiskirchen R,Trautwein C.Liver function critically determines serum retinol-binding protein 4(RBP4)levels in patients with chronic liver disease and cirrhosis[J].Hepatology,2008,48(5):1724-1725.
  • 9Kwon JH,Park ST,Kim GD,et al.The value of serum retinol-binding protein 4levels for determining disease severity in patients with chronic liver disease[J].Korean J Hepatol,2009,15(1):59-69.
  • 10Choudhury J,Sanyal AJ.Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease[J].Clin Liver Dis,2004,8(3):575-594.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部